Unicorn Bio

Unicorn Bio

Private
Sheffield, EnglandHealthcare & Life Scienceshttps://unicornb.io

Last Round

Seed

Apr 21, 2022

Total Funding Raised

$3.2M

Momentum Score

25 /100

Company Overview

Unicorn Biotechnologies is a UK-based biotechnology company that develops automated biomanufacturing platforms to scale cell production for the cultivated meat and cell therapy industries. Founded in 2020 by Dr. Adam Glen and Jack Reid, the company aims to industrialize the production of mammalian cells by developing systems that reduce labor, variability, and costs. Its technology integrates hardware, software, and cloud computing to streamline workflows and enable seamless scaling from research to commercial manufacturing. The company raised a $3.2 million seed round in 2022 to advance its mission of providing the 'picks and shovels' for the bioeconomy.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Application

Keywords

automated biomanufacturingcell manufacturingautomated bioreactorscultivated meatlab-grown meatcell therapybioprocess automationlab automationbiomanufacturing platformmammalian cell culturerobotic bioreactorsbiotech equipmentregenerative medicineCell manufacturing as a Servicefood tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unicorn Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Unicorn Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedApr 21, 2022
Pre SeedAug 25, 2021

Unicorn Bio Investors

Notable investors and investment history

Unicorn Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Unicorn Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Unicorn Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSheffield, England
Employee Range15
Year Founded2020
Last FundingApr 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.